Por favor, use este identificador para citar o enlazar este ítem:
http://conacyt.repositorioinstitucional.mx/jspui/handle/1000/5376| Broad Spectrum Antiviral Agent Niclosamide and Its Therapeutic Potential. | |
| Xu Jimin. Shi Pei-Yong. Li Hongmin. Zhou Jia. | |
| Acceso Abierto | |
| Atribución-NoComercial-SinDerivadas | |
| 10.1021/acsinfecdis.0c00052 | |
| The recent outbreak of coronavirus disease 2019 (COVID-19) highlights an urgent need for therapeutics. Through a series of drug repurposing screening campaigns, niclosamide, an FDA-approved anthelminthic drug, was found to be effective against various viral infections with nanomolar to micromolar potency such as SARS-CoV, MERS-CoV, ZIKV, HCV, and human adenovirus, indicating its potential as an antiviral agent. In this brief review, we summarize the broad antiviral activity of niclosamide and highlight its potential clinical use in the treatment of COVID-19. | |
| ACS infectious diseases | |
| 2020 | |
| Artículo | |
| https://pubs.acs.org/doi/pdf/10.1021/acsinfecdis.0c00052 | |
| Inglés | |
| VIRUS RESPIRATORIOS | |
| Aparece en las colecciones: | Artículos científicos |
Cargar archivos:
| Fichero | Tamaño | Formato | |
|---|---|---|---|
| 1108982.pdf | 1.18 MB | Adobe PDF | Visualizar/Abrir |